FDA Drug Application (020925) for TAVIST-1 by NOVARTIS

Back to FDA Applications sponsored by NOVARTIS

Application Number020925
Product Number001
FormTABLET;ORAL
Dosage1.34MG
Product Market Status Over The Counter
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameTAVIST-1
Active IngredientCLEMASTINE FUMARATE

Active IngredientCount
List of drugs with Active Ingredient CLEMASTINE FUMARATE4


Back to FDA Applications sponsored by NOVARTIS